COMMUNIQUÉS West-GlobeNewswire

Ceapro Inc. Reports 2018 First Quarter Results
17/05/2018
EDMONTON, Alberta, May 17, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”) , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for [...]
Atara Biotherapeutics to Present Long-Term Tab-cel™ Phase 2 Clinical Outcomes for Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas at 23rd Congress of European Hematology Association
17/05/2018
SOUTH SAN FRANCISCO, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with [...]
Trading by management and close relations of management
17/05/2018
Read the full announcement in the attached file Attachment 2018_34_Trading_by_management_EN
SELLAS Life Sciences to Present Phase 1/2 Clinical Data of Galinpepimut-S (GPS) in Ovarian Cancer at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
17/05/2018
Clinical and Regulatory Advisory Board Meetings for NeuVax in Triple Negative Breast Cancer on May 30, and May 31, 2018 NEW YORK, May 17, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS [...]
Esperite NV (ESP) with The Cell Factory has signed the agreement with the PHARM CRO to start preparation for the first-in-man clinical trials in treatment of Crohn's disease.
17/05/2018
Amsterdam, The Netherlands -17 th May 2018 Esperite's The Cell Factory has signed today the agreement with PHARM, the Italian CRO company which is preparing for the first-in-man clinical trials using CF-MEV-107 EVs. A [...]
Golden Leaf Holdings Signs Letter of Intent to Acquire Nevada and California Cannabis Cultivation Facilities
17/05/2018
Transaction would accelerate build-out of vertically integrated model in high-growth target markets TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB: [...]
Ultragenyx and Kyowa Kirin Announce Topline Phase 3 Study Results Demonstrating Superiority of Crysvita® (burosumab) Treatment to Oral Phosphate and Active Vitamin D in Children with X-Linked Hypophosphatemia (XLH)
17/05/2018
Substantial Healing of Rickets Observed in 72% of Patients Treated with Crysvita Compared to 6% of Patients Receiving Conventional Therapy at 40 Weeks NOVATO, Calif. and TOKYO and LONDON, May 17, 2018 (GLOBE NEWSWIRE [...]
Nuvectra to Present at Two Upcoming Investor Conferences
17/05/2018
PLANO, Texas, May 17, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR ), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief [...]
SB208 Increases Daily Nail Growth Rate over Four Weeks of Treatment
17/05/2018
Novan to Present Clinical Data from SB208 Onychomycosis Development Program at International Investigative Dermatology Meeting MORRISVILLE, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") ( [...]
BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
17/05/2018
$50 Million Equity Financing Led By Broadfin Announced Separately Today Three New Independent Directors Selected by Broadfin Added To Board; Four Current Independent Directors Retiring Amends Senior Credit Facility with [...]
BioDelivery Sciences Announces Pricing of $50 Million Equity Financing
17/05/2018
RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) today announced that it has entered into definitive agreements with existing institutional and other accredited [...]
BioSyent Schedules Q1 2018 Earnings Release for May 30, 2018
17/05/2018
TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture:RX) will be reporting its financial results for the first quarter ended March 31, 2018 on Wednesday, May 30, 2018. A [...]
Journal of Clinical Psychiatry Publishes Positive Results of Cognitive Performance From Phase 2B Trial of Roluperidone, Under Development by Minerva Neurosciences for the Treatment of Negative Symptoms in Schizophrenia
17/05/2018
WALTHAM, Mass., May 17, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders [...]
Celtaxsys Announces Last Patient, Last Visit in Landmark CF Phase 2b Lung Function Preservation Trial, Clinical Results Expected in July
17/05/2018
-Phase 2b Trial Design and Enrolled Patient Demographics to be Presented at the 41st European Cystic Fibrosis Society Conference ATLANTA, May 17, 2018 (GLOBE NEWSWIRE) -- Celtaxsys, Inc., a clinical stage pharmaceutical [...]
Incysus Therapeutics’ Scientific Co-Founder Lawrence Lamb, Ph.D. and Marcela Maus, M.D., Ph.D. to Co-Chair Gene Therapy Symposium During 2018 ASGCT Meeting
17/05/2018
Symposium Title: “Tipping Point: Gene Therapy Entering the Market” Bruce Levine, Ph.D. to Present: “Regulatory and Technical Lessons Learned in Transfer of Gene Therapy Products from Academia to Industry” NEW YORK, May [...]
Inovio Pharmaceuticals Demonstrates PSA Stabilizing Effect of INO-5150 Immunotherapy in Phase 1b Study for Prostate Cancer
17/05/2018
PLYMOUTH MEETING, Pa., May 17, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today announced a poster presentation of additional prostate cancer data (Abstract #229675) at the American Society of [...]
Immutep to Present Interim Results from TACTI-mel Clinical Trial in Global Webcast
17/05/2018
Chief Medical Officer Dr. Frederic Triebel to Present at the 3rd Annual Advances in Immuno-Oncology Congress SYDNEY, Australia, May 17, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) ("Immutep“ or “ [...]
Tetra Natural Health Signs a Supply Agreement with Namaste Technologies for the Marketing and Distribution of Rx Princeps™, its Premium Medicinal Cannabis Product
17/05/2018
OTTAWA, May 17, 2018 (GLOBE NEWSWIRE) -- Tetra Natural Health a division of Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V: TBP ) (OTCQB:TBPMF) and - Namaste Technologies Inc. (“Namaste” or the “Company”) (TSX- [...]
Progressive Care Reports 30% Increase in Year-over-Year Prescriptions Filled During April 2018
17/05/2018
MIAMI, May 17, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company, today announced that the company experienced continued year-over-year growth in its [...]

Pages